MilliporeSigma has launched its BioReliance Product Characterization Portfolio of tests for quality assessment of biologics. This new suite of tests provides critical information biologic manufacturers need to design production processes. The purity, safety and efficacy of a drug must be identified and continuously monitored in order to support development and meet regulatory requirements necessary for commercialization. Manufacturers can better understand their molecule’s function through compa...